AU Patent

AU6004799A — Remedies or preventives for ischemic reflow failure

Assigned to Shionogi and Co Ltd · Expires 2000-05-01 · 26y expired

What this patent protects

A composition for treating or preventing ischemia reperfusion injury which contains an sPLA2 inhibitor as an active ingredient.

USPTO Abstract

A composition for treating or preventing ischemia reperfusion injury which contains an sPLA2 inhibitor as an active ingredient.

Drugs covered by this patent

Patent Metadata

Patent number
AU6004799A
Jurisdiction
AU
Classification
—
Expires
2000-05-01
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.